Ecbosure 100 mcg/ml Injection 1 ml Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
CARBETOCIN-100MCG
Uses:
Ecbosure 100 mcg/ml Injection 1 ml is used in the treatment of Postpartum haemorrhage and uterine atony. The detailed uses of Ecbosure 100 mcg/ml Injection 1 ml are as follows:<br/>• Prevent postpartum hemorrhage: Ecbosure 100 mcg/ml Injection 1 ml promotes strong and sustained uterine contractions immediately after childbirth, reducing the risk of excessive bleeding due to uterine atony.<br/>• Support cesarean section recovery: Ecbosure 100 mcg/ml Injection 1 ml is administered after elective cesarean delivery under spinal or epidural anesthesia to stabilize uterine tone and minimize blood loss.<br/>• Mimic oxytocin activity: Ecbosure 100 mcg/ml Injection 1 ml acts as a long-acting oxytocin receptor agonist, binding to receptors in the uterine muscle to increase contraction frequency and intensity.<br/>
Medicinal Benefits:
Ecbosure 100 mcg/ml Injection 1 ml belongs to the group of medicines called oxytocic agents indicated for the prevention of uterine atony and postpartum haemorrhage following cesarean section under epidural or spinal anaesthesia. Ecbosure 100 mcg/ml Injection 1 ml contains Carbetocin, which is similar to oxytocin, which is naturally produced by the body and helps the womb contract during childbirth. Ecbosure 100 mcg/ml Injection 1 ml makes the womb contact and reduces the risk of bleeding.
Ecbosure 100 mcg/ml Injection 1 ml is used to treat Postpartum haemorrhage and uterine atony.
Ecbosure 100 mcg/ml Injection 1 ml makes the womb contact and reduces the risk of bleeding.
Ecbosure 100 mcg/ml Injection 1 ml may cause nausea or vomiting as a side effect. It is not necessary for everyone receiving Ecbosure 100 mcg/ml Injection 1 ml to experience this side effect. However, if the condition persists or worsens, consult a doctor.
Ecbosure 100 mcg/ml Injection 1 ml may be indicated in the management of uterine atony. Uterine atony refers to a weak and soft uterus after childbirth.